EMOSIS Announces an Exclusive Distribution Agreement with 5-Diagnostics and the Start of Commercialization

14 June 2018

Emosis, a medical device company specializing in cytomolecular diagnostics of hemostasis disorders, and 5-Diagnostics (5-D), a worldwide distributor for hemostasis products and In-Vitro Diagnostics